A

welcome letter

On behalf of the Upper Diabetes Association, I warmly welcome each and every one of you to the 14th Conference of UEDA.

Over the last decade, Diabetes management has been of a great concern both nation- ally and internationally, which necessitates collaborative working from all the health professionals interested in diabetes field. This has always been UEDA’s vision; to gath- er inspired and motivated doctors and go through the most recent strategies and up- dates together in order to come out with resolutions for better diabetes management.

We have invited the most eminent professional speakers from all Egyptian universities along with a wide base of juniors in order to exchange knowledge. We have set our sessions for this conference to include the most recent topics related to diabetes management as: Prediabetes, progression in the pathophysiology of diabetes, diabetes technology, different types of diabetes, what is new in diabetic nephropathy, retinopathy and cardio- myopathy, lastly, controversies in pharmacotherapies and Diabetes across age groups.

On the sideline of the conference three workshops will be held for doctors to increase their knowledge in endocrinology: Thyroid disorders, growth disorders and metabolic bone dis- orders. Another workshop for nurses working in preparing them as diabetes educators.

I therefore take this opportunity to thank you for being part of this conference, which will contribute to reshaping the management strategies for dealing with Diabetes. Whether you are a Speaker, Session chairperson, Sponsor or just an attendee, you will realize the great benefits in attending the 14th UEDA Conference in Luxor, the land of treasures,

We hope you will join us for a symphony of outstanding science, and take a little extra time to enjoy the spectacular and unique beauty of Luxor.

Conference Chairman Prof.Lobna El-Toony Professor of Assiut Faculty of Medicine

02 Ueda board

UEDA President Adel A. El-Sayed

Vice President Lobna Farag El-Toony

Secretary General Mesbah Sayed Kamel

Board Member Emad Hamed

Board Member Khaled El-Sayed El-Hadidy

Board Member Mohamed Mashahit

03 National Faculty

Alaa Abdel Salam, Menofya Mabahig Soka, Alex Aml Khalifa, Magdy Helmy, Alex Amr El-Miligy, Megahed Abu El-Magd, Mansoura Ashraf Talaat, Banha Mamdouh El-Nahas, Mansoura Assem Zyada, Cairo Mohamed Assi, Zagazig Ehab Salem, Zagazig Mohamed Awad, Zagazig Eman Thabet, Sohag Mohamed Fahmy Abdel-Aziz, Cairo Engy Abdel Wahab, Mohamed Kamar, Zagazig Doaa Khattab, Fayoum Mohamed Nabil Atta, Alex Fahmy Amara, Alex Mohamed Sallam, Zagazig Fareed Fawzy, Zagazig Mohamed Yakout, Zagazig Fatma Abu Bakr, Assuit Osama Abdel-Azeem, Cairo Fawzy El-Mosalamy, Zagazig Raafat Rashwan, Zagazig Ghada El-Sagheer, Minia Ragheb Refaai, Mansoura Hala El-Ebidy, Rania Shoier, Hanaa Kandeel, Azhar Rawya Khater, Cairo Hanan Mahmoud, Assuit Salah Argoon, Assuit Hazem Samy, Beni Suef Sherine Abdel-Ghaffar, Cairo Hemat Elewa, Cairo Talaat Abdel-Aty, Alex Hesham El-Hefnawy, NIDE Thoria Mohamed, Beni Suef Ibrahim Sabry, Wael Farrag, Tanta Iman El-Shorbagy, Zagazig Walaa Anwar, Assuit Lotfy Abu El-, Sohag Yasser Abdel Reaouf, Tanta Khadiga Al-Ashmawy, Cairo Yehia Ghanem, Alex

04 general information LUXOR Luxor was the ancient city of Thebes, the great capital of (Upper) Egypt during the New Kingdom, and the glorious city of Amun, later to become the god Amun-Ra. The city was regarded in the Ancient Egyptian texts as w3s.t (approximate pronunciation: “Waset”), which meant “city of the sceptre” and also as t3 ip3t (conventionally pronounced as “ta ipet” and meaning “the shrine”) and then, in a later period, the Greeks called it Thebai and the Romans after them Thebae. Thebes was also known as “the city of the 100 gates”, sometimes being called “southern Heliopolis” (‘Iunu-shemaa’ in Ancient Egyptian), to distinguish it from the city of Iunu or Heliopolis, the main place of worship for the god Re in the north. It was also often re- ferred to as niw.t, which simply means “city”, and was one of only three cities in Egypt for which this noun was used (the other two were Memphis and Heliopolis); it was also called niw.t rst, “southern city”, as the southernmost of them. The importance of the city started as early as the 11th Dynasty, when the town grew into athriving city, by native nubi Egyptian, it was renowned for its high so- cial status and luxury, but also as a center for wisdom, art, religious and political supremacy.[7] Montuhotep II who united Egypt after the troubles of the first in- termediate period brought stability to the lands as the city grew in stature. The Pharaohs of the New Kingdom in their expeditions to Kush, in today’s northern Sudan, and to the lands of Canaan, Phoenicia and Syria saw the city accumulate great wealth and rose to prominence, even on a world scale.[7] Thebes played a major role in expelling the invading forces of the Hyksos from Upper Egypt, and from the time of the 18th Dynasty to the 20th Dynasty, the city had risen as the political, religious and military capital of . The city attracted peoples such as the Babylonians, the Mitanni, the Hittites of Anatolia (modern-day Turkey), the Canaanites of Ugarit, the Phoeni- cians of Byblos and Tyre, the Minoans from the island of Crete. A Hittite prince from Anatolia even came to marry with the widow of Tutankhamun, Ankhe- senamun. The political and military importance of the city, however, faded during the Late Period, with Thebes being replaced as political capital by several cities in Northern Egypt, such as , Sais and finally . However, as the city of the god Amon-Ra, Thebes remained the religious capital of Egypt until the Greek period. The main god of the city was Amon, who was worshipped together with his wife, the Goddess Mut, and their son Khonsu, the God of the moon. With the rise of Thebes as the foremost city of Egypt, the local god Amon rose in importance as well and became linked to the sun god Ra, thus creating the new ‘king of gods’ Amon-Ra. His great temple, at Karnak just north of Thebes, was the most important temple of Egypt right until the end of antiquity. Later, the city was attacked by Assyrian emperor Assurbanipal who installed the Libyan prince on the throne, Psamtik I.[7]The city of Thebes was in ruins and fell in significance. However, Alexander the Great did arrive at the temple of Amun, where the statue of the god was transferred from Karnak during the Opet Festival, the great religious feast. Thebes remained a site of spirituality up to the Christian era, and attracted numerous Christian monks in the Roman Empire who established monasteries amidst several an- cient monuments including the temple of Hatshepsut, now called Deir el-Bahri (“the north- ern monastery”). 05 organizational notes

Registration Hours

> Registration desk will be ready on Wednesday 6th February 2019 at 02:00 PM > Registration desk will be ready on Thursday 7th February 2019 at 08:00 AM > Registration desk will be ready on Friday 8th February 2019 at 01:00 PM

Language The Official Language is English All lectures and presentations will be held in English Language . There will be no translation available .

Website www.uedaegypt.org

Weather

Wednesday 6th February 2019 Hi 27 Low 7 Partly sunny Thursday 7th February 2019 Hi 19 Low 6 Sunny Friday 8th February 2019 Hi 20 Low 8 Sunny

Important Notes

Please, Wear your conference badges all the time as attendees will not be allowed to be present in the conference premises without their personal badges. Smoking is absolutely forbidden. Mobile phones should be set to silent or powered off during all conference sessions. Children will not be allowed to enter the conference area.

06 sponsering companies

07 scientific program

Wednesday, 6 FEB 2019

01:00 PM Lunch 60 min.

02:00 PM Registration 60 min.

Thyroid Session 03:00 PM - 04:45 PM “Ramses Meeting Room“ Moderator: Lobna El Toony, Assuit 03:00 PM Dermopathy of Thyropathy 20 min. Mohamed Nabil Atta, Alex 03:20 PM Dilema of Thyroid Nodules 20 min. Iman El-Shorbagy, Zagazig 03:40 PM Thyroid Disorders During Pregnancy 20 min. Lobna El-Toony, Assuit 04:00 PM Meet the Experts 45 min. Hanaa Kandeel, Azhar Hanan Mahmoud, Assuit Mabahig Soka, Alex Yasser Abdel Reaouf, Tanta Session 1 03:00 PM - 04:10 PM Chairpersons: Emad Hamed Mohamed Mashahit Raafat Rashwan Ragheb Refaai

03:00 PM Prediabetes 20 min. Adel El Sayed, Sohag 03:20 PM Pathogenic Progress in Type 2 DM 20 min. Megahed Abu El-Magd, Mansoura 03:40 PM Comprehensive Follow up of Diabetes 20 min. Mesbah Kamel, Minia 04:00 PM Discussion 10 min.

08 -HI-EG-0105 P

It begins with a promise to discover Medicines that make life better.

5th settlement, , Egypt Phone: +202 26965300 Fax: +202 26965366 scientific program

Session 2 ( Debate: Old Antidiabetics VS New Antidiabetics ) 04:10 PM - 05:20 PM Chairpersons: Fatma Abu Bakr Fawzy El Mosalamy Khaled El-Hadidy Mohamed Yakout

04:10 PM What is After Metformin Failure : Old Antidiabetics 20 min. Adel El Sayed, Sohag 04:30 PM What is After Metformin Failure : New Antidiabetics 20 min. Fareed Fawzy, Zagazig 04:50 PM PAD 20 min. Walaa Anwar, Assiut 05:10 PM Discussion 10 min.

05:20 PM Opening 30 min.

Session 3 05:50 PM - 06:35 PM Moderator: Adel El Sayed

05:50 PM Living with Diabetes 45 min.

Session 4 06:35 PM - 07:45 PM Chairpersons: Hala El-Ebidy Mabahig Soka Mesbah Kamel Salah Argoon 06:35 PM Overview of Obesity 20 min. Lobna El Toony, Assuit 06:55 PM Diabetes Remission : The Role of Diet 20 min. Emad Hamed, 07:15 PM Bariatric Surgery in Diabetes Management 20 min. Fawzy El Mosalamy, Zagazig 07:35 PM Discussion 10 min.

10

scientific program

Sanofi Symposium 07:45 PM - 08:00 PM Chairpersons: Fareed Fawzy Lobna El-Toony Mesbah Kamel

04:10 PM Toujeo Bright Study 15 min. Mohamed Mashahit, Fayoum Liptis Symposium 08:00 PM - 08:30 PM Chaipersons: Khaled El-Hadidy Megahed Abu El-Magd Mohamed Mashahit 08:00 PM Management of Diabetic Dyslipedmia 30 min. Lobna El-Toony, Assuit Novo Nordisk Symposium 08:30 PM - 09:30 PM Chairpersons: Fawzy El Mosalamy Mabahig Soka Mesbah Kamel 08:30 PM Co-formulation: The New Generation of Insulins Combination 30 min. Khaled El-Hadidy, Beni Suef Boehringer Ingelheim Symposium 09:00 PM - 09:15 PM Chairpersons: Emad Hamed Khaled El-Hadidy Raafat Rashwan 09:00 PM Achieving Additional Cardio Protection in T2D Management 15 min. Mesbah kamel, Minia

12

scientific program

Thursday, 7 FEB 2019

Development and Prolactin Session 09:00 AM -10:45 AM “Ramses Meeting Room“ Moderator: Khaled El -Hadidy, Beni-Suef Assistant Moderator: Hazem Samy, Beni-Suef Thoria Mohamed, Beni-Suef 9:00 AM Short Stature 20 min. Hanaa Kandeel, Azhar 9:20 AM Delayed Puberty 20 min. Amr El-Miligy, Cairo 9:40 AM Hyperprolactinemia 20 min. Khaled El -Hadidy, Beni Suef 10:00 AM Meet the Experts 45 min. Assem Zyada, Cairo Engy Abdel Wahab, Tanta Khadiga Al-Ashmawy, Cairo Mohamed Fahmy Abdel-Aziz, Ain Shams Rawya Khater, Cairo

Session 5 ( Diabetes in certain populations ) 09:00 AM - 10:10 AM Chairperson: Lotfy Abu El-Dahab Mohamed Awad Raafat Rashwan Yasser Abdel Reaouf

09:00 AM Diabetes and Pregnancy 20 min. Wael Farrag, Tanta 09:20 PM Transient Diabetes 20 min. Ehab Salem, Zagazig 09:40 PM HbA1c: Pitfalls in Practice 20 min. Magdy Helmy, Alex 10:00 PM Discussion 10 min.

14

scientific program

Session 6 ( Hot Topics ) 10:10 AM - 11:20 AM Chairperson: Fahmy Amara Hanan Mahmoud Hemat Elewa Ibrahim Sabry Iman El-Shorbagy 10:10 AM Diabetes and HCV 20 min. Ashraf Talaat, Banha 10:30 AM Burden of Diabetes: Egyptian Screening Program 20 min. Hesham El-Hefnawy, NIDE 10:50 AM Post Transplant Diabetes 20 min. Yehia Ghanem, Alex 11:10 AM Discussion 10 min.

Session 7 ( Diabetic complications ) 11:20 AM - 12:30 PM Chairpersons: Aml Khalifa Ashraf Talaat Ehab Salem Khaled El-Hadidy Rawya Khater

11:20 AM Diabetes Nephropathy 20 min. Osama Abdel-Azeem, Cairo 11:40 AM Updates in Diabetic Dyslipdemia 20 min. Talaat Abdel-Aty, Alex 12:00 PM Diabetic Technology 20 min. Mohamed Kamar, Zagazig 12:20 PM Discussion 10 min.

16

scientific program

Lilly Symposium 12:30 PM - 01:00 PM Chairpersons: Ehab Salem Lobna El-Toony Magdy Helmy

12:30 PM Trulicity Preferred 1st Injectable for T2DM 30 min. Mesbah kamel, Minia Servier Symposium 01:00 PM - 02:00 PM Chaipersons: Adel El Sayed Khaled El-Hadidy Lobna El-Toony Mesbah kamel Mohamed Mashahit 01:00 PM SUs in Recent Guidelines 15 min. Adel El Sayed, Sohag 01:15 PM The dose of Evidence 15 min. Mesbah kamel, Minia 01:30 PM Managing Hypertension, Numbers Always say the Truth 15 min. Khaled El-Hadidy, Beni Suef 01:45 PM The missing piece 15 min. Lobna El-Toony, Assuit Novartis Symposium 02:00 PM - 02:30 PM Chairpersons: Lobna El-Toony Mesbah Kamel Osama Abdel-Azeem 02:00 PM Criteria to be considered while treating T2D patient 30 min. Mohamed Mashahit, Fayoum MSD Symposium 02:30 PM - 03:00 PM Chairpersons: Adel El Sayed Mesbah Kamel Mohamed Kamar 02:30 PM The Debatable Question: What to Add after Metformin for T2DM Patients? 30 min. Lobna El-Toony, Assuit Astra Symposium 03:00 PM - 03:15 PM Chairpersons: Ashraf Talaat Khaled El-Hadidy Lobna El-Toony 03:00 PM SGLT2-Inhibitors: Moving from Neutrality to Benefits 15 min. Yehia Ghanem, Alex LUNCH

18 -HI-EG-0105 P

It begins with a promise to discover Medicines that make life better.

5th settlement, New Cairo, Egypt Phone: +202 26965300 Fax: +202 26965366 scientific program

Friday, 8 FEB 2019

01:00 PM Lunch 60 min.

Bone Session 02:00 PM - 03:45 PM “Ramses Meeting Room“ Moderator: Mohamed Mashahit, Fayoum Assistant Moderator: Doaa Khattab, Fayoum 02:00 PM Osteoporosis Updates 20 min. Ghada El Sagheer, Minia 02:20 AM PTH-vit D and it’s Role in Calcium Metabolism 20 min. Assem Zyada, Cairo 02:40 AM Parathyroid Disorder in Practice 20 min. Mohamed Mashahit, Fayoum 03:00 AM Meet the Experts 45 min. Khadiga Al-Ashmawy, Cairo Assem Zyada, Cairo Fahmy Amara, Alex Session 8 02:00 PM - 03:10 PM Chairperson: Emad Hamed Eman Thabet Mohamed Sallam

02:00 PM Update in Type1 Diabetes 20 min. Sherine Abdel-Ghaffar, Cairo 02:20 PM Type 2 Diabetes in Children 20 min. Alaa Abdel Salam, Menofya 02:40 PM Inhospitable management of diabetes 20 min. Khaled El-Hadidy, Beni Suef 03:00 PM Discussion 10 min.

20

scientific program

Session 9 (Diabetic complications ) 03:10 PM - 04:20 PM Chairperson: Fawzy El Mosalamy Mohamed Assi Rania Shoier Wael Farrag 03:10 PM Type 3 Diabetes 20 min. Yasser Abdel Reaouf, Tanta 03:30 PM Diabetic Neuropathy 20 min. Mamdouh El-Nahas, Mansoura 03:50 PM Diabetic Cardiomyopathy 20 min. Hemat Elewa, Cairo 04:10 PM Discussion 10 min.

Session 10 ( Diabetes in certain populations ) 04:20 PM - 05:30 PM Chairpersons: Alaa Abdel Salam Mohamed Mashahit Yasser Abdel Reaouf

04:20 PM Secondary Diabetes 20 min. Mohamed Awad, Zagazig 04:40 PM Diabetic Ketoacidosis 20 min. Salah Argoun, Assuit 05:00 PM Diabetes in Elderly 20 min. Mohamed Sallam, Zagazig 05:20 PM Discussion 10 min.

Session 11 05:30 PM - 06:40 PM Chairpersons: Ehab Salem Mohamed Assi Mohamed Nabil Atta 05:30 PM Future of Diabetes Management 20 min. Diaa Ewais, KSA 05:50 PM Erectile Dysfunction in Diabetics 20 min. Mohamed Abdel Raouf, Alex 06:10 PM Diabetic retinopathy 20 min. Mohamed Mashahit, Fayoum 06:30 PM Closing Ceremony 10 min.

22

EGA/TB/0616/0270

References: 1. Rodbard HW, Cariou B, Zinman B, Handelsman Y, Philis-Tsimikas A, Skj0th TV, Rana A, Mathieu C on behalf of the BEGIN Once Long Trial Investigators. Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial. DIABETIC Medicine 2013;30(11): 1298-304. 2. Bode BW, Buse JB, Fisher M, Garg SK, Marre M, Merker L, Renard E, Russell-Jones DL, Hansen CT, Rana A, Heller SR on behalf of the BEGIN Basal-Bolus Type 1 Trial Investigators. Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN Basal-Bolus Type 1): 2-year results of a randomized clinical trial. Diabetic Medicine 2013;30(11):1293-297. 3. Tresiba approved insert leaflet by Egyptian Ministry of health on 11.08.2015. 4. Jonassen I, Havelund 5, Hoeg-Jensen T, et al. Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin. Pharmaceutical Research 2012;29(8):2104-14. EGA/TB/0616/0270

References: 1. Rodbard HW, Cariou B, Zinman B, Handelsman Y, Philis-Tsimikas A, Skj0th TV, Rana A, Mathieu C on behalf of the BEGIN Once Long Trial Investigators. Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial. DIABETIC Medicine 2013;30(11): 1298-304. 2. Bode BW, Buse JB, Fisher M, Garg SK, Marre M, Merker L, Renard E, Russell-Jones DL, Hansen CT, Rana A, Heller SR on behalf of the BEGIN Basal-Bolus Type 1 Trial Investigators. Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN Basal-Bolus Type 1): 2-year results of a randomized clinical trial. Diabetic Medicine 2013;30(11):1293-297. 3. Tresiba approved insert leaflet by Egyptian Ministry of health on 11.08.2015. 4. Jonassen I, Havelund 5, Hoeg-Jensen T, et al. Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin. Pharmaceutical Research 2012;29(8):2104-14.

-HI-EG-0105 P

It begins with a promise to discover Medicines that make life better.

5th settlement, New Cairo, Egypt Phone: +202 26965300 Fax: +202 26965366 notes ......

......

......

......

......

......

......

......

......

......

......

......

......

......

......

......

......

......

......

......

......

......

31

32